Amazing Mars Anomalies NASA Image Shows Mayan Like Face Sculptures And Earth Like Lake Houses – Video


Amazing Mars Anomalies NASA Image Shows Mayan Like Face Sculptures And Earth Like Lake Houses
Amazing Mars Anomalies in one of the most recent NASA images taken by the Mars Curiosity Rover.In this image we can see what appear to be Earth like lakeside houses , a sculpture that has several.

By: UniversalTrek

Link:

Amazing Mars Anomalies NASA Image Shows Mayan Like Face Sculptures And Earth Like Lake Houses - Video

MUST SEE ! — NASA Reveal’s Evidence Of Past Life On Mars SOL – 778 Anomaly, Artifacts, UFO’s – Video


MUST SEE ! -- NASA Reveal #39;s Evidence Of Past Life On Mars SOL - 778 Anomaly, Artifacts, UFO #39;s
PLEASE WATCH IN 1080P HD TO GET THE MOST OUT OF MY VIDEOS ! http://mars.jpl.nasa.gov/msl/multimedia/raw/?rawid=0778MR0033700270404022E01_DXXX s=778 Please check out our ...

By: TRUTHSEEKER

Follow this link:

MUST SEE ! -- NASA Reveal's Evidence Of Past Life On Mars SOL - 778 Anomaly, Artifacts, UFO's - Video

MAVEN! NASA’s Latest Mars Spacecraft Reveals Secrets Behind Planets Atmosphere! – Video


MAVEN! NASA #39;s Latest Mars Spacecraft Reveals Secrets Behind Planets Atmosphere!
http://www.undergroundworldnews.com MAVEN, the NASA statement claims, has provided scientists their first look at a storm of energetic solar particles at Mars, produced unprecedented ultraviolet...

By: DAHBOO77

See the original post:

MAVEN! NASA's Latest Mars Spacecraft Reveals Secrets Behind Planets Atmosphere! - Video

Federal Eye: NASA maintains lofty worker-satisfaction ratings for 2014

National Aeronautic and Space Administration employees remained largely satisfied with their agency this year, likely continuing the agencys trend ofrankingamong the best places to work in the federal government, according to results from a recent survey.

Seventy-one percent of NASA staffers whoresponded to theOffice of Personnel Managements federal-employee viewpoints survey gave the agency a positive mark this year when asked about their overall impression of the organization.

NASA in 2013earned the highest composite score among all federal agencies for the second consecutive year. In this yearssurvey, the organization showed improvements in 56 categories, while itsnumbers dropped slightly with13 measures of worker satisfaction, according to a summary of the results.

Among the areas with the most room for improvement, the agency scored relatively low onperformance pay, career-advancement opportunities, and satisfaction with senior leadership.

More than two-thirds of respondents indicated that pay raises are not based on performance, and about 58 percent saidthe agency does not effectively deal with workers who do a poor job. About 51 percent of the employees saidthey are not satisfied with opportunities for advancement, and 22 percent said they do not have a high level of respect for senior leaders.

However, NASA staffersexpressed a great dealof enthusiasm for their work, with 97 percent of respondents saying they are willing to put in extra effort to complete a job and more than 88 percent saying they view their workas important.

Sixty-three percent of the employees said NASA rewards creativity and innovation, while nearly 78 percent said they feelencouraged to come up with new and better ways of doing things.

Among six programs designed to improve work-life balance,more thantwo-thirds of respondents saidthey are satisfied witheach of them. Nearly 95 percent gave positive marks to NASAs alternative work schedules,and about 87 percent indicated they are happy with telework options.

Although NASAs survey results are available online, no federal agencies havepublicized their numbersyet. The Office of Personnel Management generally announces the results in November or December, and the nonprofit Partnership for Public Service uses them for its annualBest Places to Work in Federal Government rankings.

Josh Hicks covers the federal government and anchors the Federal Eye blog. He reported for newspapers in the Detroit and Seattle suburbs before joining the Post as a contributor to Glenn Kesslers Fact Checker blog in 2011.

Original post:

Federal Eye: NASA maintains lofty worker-satisfaction ratings for 2014

NASA Probe Snaps First Photos of Mercury's Water Ice

The first-ever photos of water ice near Mercury's north pole have come down to Earth, and they have quite a story to tell.

The images, taken by NASA's MESSENGER spacecraft (short for MErcury Surface, Space ENvironment, GEochemistry, and Ranging), suggest that the ice lurking within Mercury's polar craters was delivered recently, and may even be topped up by processes that continue today, researchers said.

NEWS: Mercury Not Too Hot For Polar Water Ice?

More than 20 years ago, Earth-based radar imaging first spotted signs of water ice near Mercury's north and south poles a surprise, perhaps, given that temperatures on the solar system's innermost planet can top 800 degrees Fahrenheit (427 degrees Celsius). [Water Ice On Mercury: How It Was Found (Video)]

In late 2012, MESSENGER confirmed those observations from orbit around Mercury, discovering ice in permanently shadowed craters near the planet's north pole. MESSENGER scientists announced the find after integrating results from thermal modeling studies with data gathered by the probe's hydrogen-hunting neutron spectrometer and its laser altimeter, which measured the reflectance of the deposits.

And now the MESSENGER team has captured optical-light images of the ice for the first time, by taking advantage of small amounts of sunlight scattered off the craters' walls.

NEWS: Spacecraft Raises Mercury Mysteries

"There is a lot new to be learned by seeing the deposits," said study lead author Nancy Chabot, instrument scientist for MESSENGERs Mercury Dual Imaging System and a researcher at the Johns Hopkins University Applied Physics Laboratory in Laurel, Maryland, in a statement.

For example, the texture of the ice at the bottom of Mercury's 70-mile-wide (113 kilometers) Prokofiev Crater suggests that the material was put in place relatively recently rather than billions of years ago, researchers said.

Images of other craters back up this notion. They show dark deposits, believed to be frozen organic-rich material, covering ice in some areas, with sharp boundaries between the two different types of material.

Read the original post:

NASA Probe Snaps First Photos of Mercury's Water Ice

Researcher receives $20 million to study oil recovery in Alberta's oilsands

Bill Graveland, The Canadian Press Published Thursday, October 16, 2014 7:01PM EDT

CALGARY -- Nanotechnology similar to that used to kill tumours in cancer patients could be adapted to improve in situ oil recovery in Alberta's oilsands, says an international researcher.

Stanley Bryant, a world-leading nanotechnology expert from the University of Texas in Austin, was introduced Thursday as the latest Canada Excellence Research Chair at the University of Calgary.

A federal energy research program awards world-renowned scientists and their teams up to $10 million over seven years to establish research programs.

"I don't need to remind this audience of the world-class petroleum resource here in Alberta. I don't need to remind this audience either of the litany of challenges associated with that resource," Bryant said at a University of Calgary ceremony.

"What we want to do is reduce the environmental impact of existing development strategies to come up with entirely new ways to extract energy involving little or even no environmental impact."

Bryant will receive $10 million from the federal government and another $10 million from the university to create a chair for materials engineering for unconventional oil reservoirs at the Schulich School of Engineering and Faculty of Science.

He said one avenue of research will be to use nanoparticles, about a thousand times smaller than red blood cells, to improve oil recovery by making steam injected into the ground even thinner.

"You can disperse these things in a liquid like water and they will stay dispersed. If you make these things out of ordinary iron oxide --which we call rust -- and you apply an oscillating magnetic field, those particles will get hot, real hot," said Bryant.

"They're already using that phenomenon to kill tumour cells in patients with incredible specificity. We want to see if we can use the same phenomenon to get heat into the oilsands and recover energy that way."

See the original post here:

Researcher receives $20 million to study oil recovery in Alberta's oilsands

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub

15.10.2014 - (idw) VDI/VDE Innovation + Technik GmbH

Berlin, Germany October 15th, 2014 A major step in implementing the ETPN Translation Hub has been reached, with three European projects entering the finalisation stage of their EU Grant Agreements. The project ENATRANS is for networking of SMEs in the nano-biomedical sector and supporting the SMEs with getting their products from the laboratory phase to the clinical applications. The projects 'NANOFACTURING' and 'NANOPILOT' will establish pilot lines to scale-up the production of novel nanopharmaceuticals from the lab-scale to the quantities needed for clinical testing. This announcement took place during the ETPN Annual Event 2014 in San Sebastian, Spain. The ENATRANS project (Enabling NAnomedicine TRANSlation) will ensure the global coherence of the Translation Hub and build a functioning supply chain of nanomedicine projects mainly ran by SMEs and ready to meet industrial and clinical needs. A Translational Advisory Board (TAB) will serve as the cornerstone to provide specific advice, guidance and recommendations to all nanomedicine actors dealing with translation issues and in need of assistance in specific areas of expertise.

Coordinator: ETPN Secretariat c/o VDI/VDE-IT (DE) Consortium: Nanobiotix (FR), CEA-Leti (FR), Bioanalytik Muenster e.V. (DE), Tel-Aviv University (IL), Fondazione Don Carlo Gnocchi ONLUS (IT), and TecMinho (PT). Duration: 3 years Budget: 2 Mio.

The NanoFacturing project has two principal objectives. Firstly to scale up an existing Good Manufacturing Practice (GMP) pilot line to a medium scale sustainable manufacturing process for solid core nanopharmaceuticals with a primary focus on glycan-coated gold nanoparticles. The process will also support consortium partners clinical programs such as IFOMs antiviral Dengue fever NP and other EU-wide nanomedicine programs. Secondly to create a large scale process platform that would serve as the basis for GMP compliant industrial manufacture and that will be available as a model for other European companies wishing to develop their own products.

Coordinator: Midatech Biogune (ES) Consortium: Centre for Process Innovation Limited (UK), Prochimia Surfaces SP.Z.O.O (PL), Galchimia S.A (ES), the University College Dublin and the National University of Ireland (IE), Applus S.A. LGAI Technological Center, S.A (ES), IFOM, Fondazione Istituto FIRC di Oncologia Molecolare (IT), and Ecole Polytechnique Federale de Lausanne (CH). Duration: 4 years Budget: 8 Mio.

The NanoPilot project will build a pilot line for the production of polymer based nanopharmaceuticals in compliance with GMP. The size of the plant aims to be very small, with three systems to be produced at the end of the project. Continuous flow microreactors will be employed for two of the nanopharmaceuticals to be manufactured.

Coordinator: the Research Centre IK4-CIDETEC (ES) Consortium : A Research Institute - UT2A-ADERA (FR); two Universities - National University of Ireland, Galway (IE) and Universidad de Santiago de Compostela (ES) ; two industries - Sylentis (ES) and Chemtrix (NL) ; and three SMEs - iX-Factory (DE), Mejoran (ES) and Spinverse (FI).

Patrick Boisseau, chairman of the ETPN, added: We are very proud to announce such important news during the ETPN Annual Event 2014. The success of the EU calls 18 proposals have been received for pilot lines for upscaling the manufacturing of nanopharmaceuticals - shows the adequacy of ETPN recommendations with real SMEs needs. We also look forward for the perspectives on a nano-characterisation infrastructure, another major pillar of the Translation Hub asked by European nanomedicine actors. The ETPN is excited to work hand in hand with the different coordinators for a global coherence of actions and a more efficient European value chain in nanomedicine.

The ETPN Annual Event 2014 is taking place in San Sebastian (Spain) from October 15th to 16th, kindly co-organised by the nanoBasque Agency (SPRI) and hosted by CIC nanoGUNE, the Basque nanoscience cooperative research centre. -- End

About ETPN http://www.etpnanomedicine.eu The European Technology Platform Nanomedicine was established in 2005 as a joint initiative of the European Commission and CEOs of large industrial companies, SMEs and academic research institutions to investigate and advance joint activities in the area of nanotechnology in medicine. Since 2005 the ETPN published a number of strategic documents, roadmaps and structural requirements for an efficient translation of R&D results into innovative nanomedicine. The ETPN supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the European Commission and the European Member States.

Continued here:

European Commission opens the gate towards the implementation of Nanomedicine Translation Hub

Walter Rosenthal Assumes Presidency of Jena University Thomas Sommer Becomes MDC Interim Director

16.10.2014 - (idw) Max-Delbrck-Centrum fr Molekulare Medizin (MDC) Berlin-Buch

On October 16, 2014, Professor Walter Rosenthal, former Chair of the Board of Directors and Scientific Director of the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch since 2009, assumed his new position as President of the Friedrich Schiller University Jena. He was elected on May 23, 2014 as successor of Professor Klaus Dicke by the University Council in consultation with the Senate of the University. On October 15, 2014, Professor Thomas Sommer became Interim Chair of the MDC Board of Directors until the appointment of a successor. From 2004 to the present, Sommer held the position of Deputy Scientific Director of the MDC. Following Professor Rosenthals departure, Professor Sommer also assumed the vacant positions of member of the Board of Directors of the Berlin Institute of Health (BIH), which was founded in 2013 by the MDC and the Charit, and member of the Board of Directors of the German Centre for Cardiovascular Research (DZHK).

Thomas Sommer studied biology at Freie Universitt Berlin. In 1988 he received his doctorate from the same university with a dissertation at the Max Planck Institute of Molecular Genetics in Berlin-Dahlem in the department of Professor Thomas A. Trautner. He then began working on the mechanisms of protein quality control as a postdoctoral fellow in the laboratory of Professor Stefan Jentsch at the Friedrich Miescher Laboratory of the Max Planck Society in Tbingen.

In 2003 Sommer was elected a member of the European Molecular Biology Organization (EMBO); in 2006 he received an honorary professorship at the Charit. In 2012, together with Professor Glickman, he received the Science Prize of the German Technion Society (Hannover).

In recent years Sommer has also become engaged in issues of the self-administration of research. Since 2014 he has been a member of the scientific advisory board of the Center for Biotechnology of the University of Duisburg-Essen. From 2006 to 2008 he was a member in the Senate Committee for Graduate Programs of the German Research Foundation (DFG), and from 2008 to 2014 he was a member in the Senate Committee for Collaborative Research Centres of the DFG.

Contact: Barbara Bachtler Press Department Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch in the Helmholtz Association Robert-Rssle-Strae 10 13125 Berlin Germany Phone: +49 (0) 30 94 06 - 38 96 Fax: +49 (0) 30 94 06 - 38 33 e-mail: presse@mdc-berlin.de http://www.mdc-berlin.de/en

Follow this link:

Walter Rosenthal Assumes Presidency of Jena University Thomas Sommer Becomes MDC Interim Director

Researchers in Berlin and Bath Identify Nave-Like Human Stem Cells

16.10.2014 - (idw) Max-Delbrck-Centrum fr Molekulare Medizin (MDC) Berlin-Buch

In their search for the earliest possible stage of development of human embryonic stem cells (hESCs) that still have the potential to develop into any types of body cells and tissue, researchers from the Max Delbrck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, and the University of Bath, United Kingdom, have apparently been successful. Jichang Wang, Gangcai Xie, and Dr. Zsuzsanna Izsvk (MDC), together with Professor Laurence D. Hurst (University of Bath), report the discovery of a subtype of cells in culture dishes with hESCs and human induced pluripotent stem cells (hiPSCs) that resemble this very early, pluripotent or nave state (Nature, doi:10.1038/nature13804)*. They also discovered the mechanism that turns human ES cells into nave-like human stem cells. While this has potential implications for medicine and for understanding early human development, an evolutionary enigma still remains unsolved.

Human embryonic stem cells (hESCs) differ considerably from those of mice. Mouse nave cultures resemble the inner cell mass which gives rise to the embryo, while none of the cultured hESC lines do. Nave ESCs of mice are easy to maintain, but not human ESCs isolated from pre-implantation embryos. The hESC lines, researchers work with in their laboratories are considered to be less nave, and have limited differentiation potential. Researchers hypothesize that they have partially lost their pluripotency. Why this is so remains unclear.

What properties characterize human nave stem cells? Can they be identified and proliferated in the laboratory and retained in culture? Researchers in Europe, Asia and the USA are trying to find the answers to these questions in order to be able to use these cells for therapy in the future.

Evolution pointed the way It was evolution that showed the researchers in Bath and Berlin the way to the successful approach. They pinpointed one particular class of ancient viruses called HERVH (human endogenous retrovirus H). HERVH integrated into our DNA millions of years ago, and although it does not function as a virus any longer, it is not silent.

HERVH-derived sequences appear at a very early stage in human embryos, that is, HERVH is highly expressed at just the right time and place in human embryos where one would expect to see nave stem cells. This was also observed by Professor Kazutoshi Takahashi (Kyoto University, Kyoto, Japan), almost at the same time when Dr. Izsvk and Professor Hurst made their discovery.**

Dr. Izsvk and Professor Hurst succeeded in going one step further. They were able to identify the switch that regulates HERVH. In hESC cultures they identified a transcription factor called LBP9 as being central to the activity of HERVH in early embryos. Using a reporter system that made cells expressing HERVH via LBP9 glow green, the Berlin and Bath team found that they had purified human ESCs that showed all the hallmarks of nave mouse stem cells.

This transcription factor was not previously known to be important to human stem cells. However, unknown to them at the time, the same transcription factor was shown by Austin Smiths group (University of Cambridge, UK) to have a role in mouse nave cells***.

Our human nave-like cells look remarkably like the mouse ones, and are close to human inner cell mass (ICM), said Jichang Wang (PhD student, MDC), first author of the Nature publication. With our HERVH-based reporter system we can easily isolate nave-like human ESCs from any human ESC culture. These cells grow like the mouse nave stem cells and express many of the same genes such as NANOG, KLF4 and OCT4 that are associated with murine navet. When we knockdown LBP9 or HERVH, these cells no longer resemble nave-like human stem cells, he added.

To explore a potential role in stem cell-based therapeutics, the next task will be to keep these isolated human nave-like stem cells in culture and proliferate them. HERVH would also be particularly useful in identifying optimal conditions for long-term culturing. As HERVH inhibits differentiation, its expression should be transient, otherwise it might be detrimental to normal embryo development. What factors keep this delicate process in balance is yet to be determined.

Read more:

Researchers in Berlin and Bath Identify Nave-Like Human Stem Cells

Startup Grind Hosts Daniel Cane (Modernizing Medicine) – Miami, FL – Video


Startup Grind Hosts Daniel Cane (Modernizing Medicine) - Miami, FL
Upcoming Miami Events - http://goo.gl/Dy5OBD Daniel is President, CEO and co-founder of Modernizing Medicine, a company that from inception has raised three rounds of financing, the most recent...

By: Startup Grind Local

Follow this link:

Startup Grind Hosts Daniel Cane (Modernizing Medicine) - Miami, FL - Video

Advanced Alternative Medicine Center Newburgh Incredible Five Star Review by… – Video


Advanced Alternative Medicine Center Newburgh Incredible Five Star Review by...
http://www.spineboy.com/ (845) 561-2225 Advanced Alternative Medicine Center Newburgh reviews New Rating Dr. Huntoon is my first phone call when I have a health concern for...

By: Richard Huntoon

Read the original:

Advanced Alternative Medicine Center Newburgh Incredible Five Star Review by... - Video